Savannah Cheeseman, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 78 Marshall Ave, Williston, VT 05495 Phone: 802-878-0388 |
Dr. Carrie Hutchins Pryor, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 71 Boxwood St, Williston, VT 05495 Phone: 802-878-9056 |
Cheryl Denise Hackett, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 78 Marshall Ave, Williston, VT 05495 Phone: 802-878-0388 |
Molly Mix Lewis, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2466 St George Rd, Cvs, Williston, VT 05495 Phone: 802-872-8840 Fax: 802-872-8841 |
Karen Wyman Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 108 Cornerstone Dr, Williston, VT 05495 Phone: 802-878-1118 |
Mr. Waldemar Z. Wierzbicki, BSPHARM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 108 Cornerstone Dr, Williston, VT 05495 Phone: 802-878-1118 |
Ms. M Jacklynn Estes, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 108 Cornerstone Dr, Williston, VT 05495 Phone: 802-878-1118 |
News Archive
CardiacAssist, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its new TandemLung oxygenator, a medical device that acts as an artificial lung to infuse oxygen and remove carbon dioxide from the blood.
In future decades the need for effective strategies for medical rehabilitation will increase significantly, because patients' rate of survival after diseases with severe functional deficits, such as a stroke, will increase.
Edmonton - Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone, Dr. Christian Constance told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
Researchers with UCLA's Jonsson Comprehensive Cancer Center have developed and used a high-throughput molecular screening approach that identifies and characterizes chemical compounds that can target the stem cells that are responsible for creating deadly brain tumors.
› Verified 9 days ago